Turoctocog alfa pegol Enrolling by Invitation Phase 3 Trials for Hemophilia A / Congenital Hematological Disorder Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02137850Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A